ストックスクリーナーアプリを入手
48.02
0.04%
0.02
アフターアワーズ：
48.02
前日終値:
$48.00
開ける：
$47.6
24時間の取引高:
933.09K
Relative Volume:
1.54
時価総額：
$2.27B
収益：
$1.10B
当期純損益:
$186.50M
株価収益率:
12.70
EPS:
3.7817
ネットキャッシュフロー:
$267.19M
1週間 パフォーマンス:
+3.40%
1か月 パフォーマンス:
-18.53%
6か月 パフォーマンス:
-19.40%
1年 パフォーマンス:
-44.00%
1日の値動き範囲:
$47.49
$48.59
1週間の範囲:
$45.71
$48.59
52週間の値動き範囲:
$42.62
$87.12
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
名前
Prestige Consumer Healthcare Inc
セクター
電話
(914) 524-6800
住所
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
48.02 | 2.27B | 1.10B | 186.50M | 267.19M | 3.7817 |
TAK
Takeda Pharmaceutical Co Adr
|
15.87 | 51.34B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.24 | 41.15B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.61 | 39.67B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
80.23 | 34.09B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
578.43 | 24.13B | 3.17B | 1.29B | 1.01B | 27.09 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-24 | アップグレード | Sidoti | Neutral → Buy |
| 2024-12-09 | ダウングレード | Sidoti | Buy → Neutral |
| 2024-06-21 | アップグレード | DA Davidson | Neutral → Buy |
| 2022-11-17 | 開始されました | Canaccord Genuity | Buy |
| 2022-05-10 | アップグレード | Jefferies | Hold → Buy |
| 2022-05-09 | アップグレード | Oppenheimer | Perform → Outperform |
| 2020-08-07 | ダウングレード | DA Davidson | Buy → Neutral |
| 2020-06-29 | アップグレード | Sidoti | Neutral → Buy |
| 2020-04-14 | ダウングレード | Jefferies | Buy → Hold |
| 2020-04-07 | 再開されました | Sidoti | Neutral |
| 2020-03-26 | アップグレード | Jefferies | Hold → Buy |
| 2020-03-24 | 開始されました | Oppenheimer | Perform |
| 2020-03-19 | アップグレード | DA Davidson | Neutral → Buy |
| 2019-01-15 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2017-12-04 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2017-06-02 | アップグレード | Jefferies | Underperform → Hold |
| 2017-05-22 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2016-12-27 | 繰り返されました | B. Riley & Co. | Buy |
| 2016-11-17 | 開始されました | Gabelli & Co | Buy |
| 2016-08-12 | アップグレード | Sidoti | Neutral → Buy |
| 2016-03-08 | 開始されました | KeyBanc Capital Mkts | Overweight |
| 2016-02-05 | 開始されました | Piper Jaffray | Overweight |
| 2015-11-30 | ダウングレード | Jefferies | Hold → Underperform |
| 2014-04-28 | 繰り返されました | B. Riley & Co. | Buy |
| 2014-04-28 | 繰り返されました | Oppenheimer | Outperform |
| 2013-07-09 | 開始されました | B. Riley & Co. | Buy |
すべてを表示
Prestige Consumer Healthcare Inc (PBH) 最新ニュース
Prestige Consumer Healthcare Inc. (PBH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Prestige Consumer Healthcare Inc. (PBH) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Trading Systems Reacting to (PBH) Volatility - Stock Traders Daily
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A 39% Upside Potential Amidst Strong Analyst Ratings - DirectorsTalk Interviews
Why Is Prestige Consumer Healthcare Stock Trending - Kalkine Media
PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Encourages Prestige Consumer Healthcare Inc. (PBH) Investors to Inquire about Securities Investigation - ACCESS Newswire
Kinetics Spin-Off and Corporate Restructuring Fund's Prestige Consumer Healthcare Inc(PBH) Holding History - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages Prestige Consumer H - The National Law Review
Prestige Consumer Healthcare, Inc. (PBH) Securities Fraud InvestigationLevi & Korsinsky - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc.PBH - PR Newswire
Levi & Korsinsky Announces Investigation of Securities Claims Against Prestige Consumer Healthcare (PBH) - GlobeNewswire
Prestige Consumer Healthcare Inc. (PBH) Q4 2026 Earnings Call Transcript Summary - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Prestige Consumer Healthcare (PBH) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
PBH Investor Alert: Levi & Korsinsky Investigates Prestige Consumer Healthcare (PBH) for Potential Securities Fraud - marketscreener.com
INVESTOR ALERT: Investigation of Prestige Consumer Healthcare Inc. (PBH) announced by Holzer & Holzer, LLC - GlobeNewswire
Prestige Consumer Healthcare (PBH) Valuation After Missed Q4 Targets And Delayed LaCorium Deal Disclosure - Sahm
PBH SHAREHOLDER INVESTIGATION: SueWallSt Investigates Prestige Consumer Healthcare for Possible Securities Law Violations - PR Newswire
Prestige Consumer Healthcare (PBH): Investor Outlook Reveals 48.88% Potential Upside - DirectorsTalk Interviews
Prestige Consumer Healthcare Q4 earnings call highlights - MSN
Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Prestige Consumer Healthcare Inc. Just Missed EPS By 8.9%: Here's What Analysts Think Will Happen Next - 富途牛牛
Prestige Consumer Healthcare: Better Valuation, But Too Much Uncertainty To Buy - Seeking Alpha
Bessemer Group Inc. Acquires 32,331 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
How InvestingPro’s Fair Value spotted Prestige Healthcare’s 46% drop By Investing.com - Investing.com
Prestige Consumer Healthcare (PBH) Is Down 11.0% After Earnings Miss And Surprise LaCorium Deal DisclosureWhat's Changed - Sahm
PBH Maintains Buy Rating, Price Target Lowered to $72 by Canacco - GuruFocus
Prestige Consumer Healthcare Balances Setbacks With Growth Plan - The Globe and Mail
Securities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire
Prestige Consumer Healthcare, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Prestige Consumer Healthcare (PBH) - Morningstar
Investigation launched over Prestige Consumer Healthcare's missed financial targets and undisclosed acquisition. - Pluang
Prestige Consumer Healthcare Inc. Just Missed EarningsBut Analysts Have Updated Their Models - Yahoo Finance
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q4 2026 Earnings Call Transcript - Insider Monkey
Prestige Consumer Healthcare Hits Day Low of $42.66 Amid Price Pressure - Markets Mojo
Prestige Consumer Healthcare Hits New 52-Week Low at $42.66 - Markets Mojo
Prestige Brands stock price target cut to $72 by Canaccord on sales miss - Investing.com Australia
Prestige Consumer Healthcare Inc. $PBH Shares Purchased by Leeward Investments LLC MA - MarketBeat
Oppenheimer downgrades Prestige Consumer Healthcare (PBH) - MSN
Prestige Consumer Healthcare Q4 Earnings Call Highlights - sharewise.com
Prestige Consumer Healthcare Inc. Overview: Major Brands, Competitive Strengths, and Growth Strategy in OTC Health Products - Minichart
PBH News | PRESTIGE CONSUMER HEALTHCARE (NYSE:PBH) - ChartMill
Prestige Consumer Healthcare Inc (PBH) Q4 2026 Earnings Call Hig - GuruFocus
Prestige Consumer Shares Slide on Weak Outlook, 4Q Underperformance - Moomoo
Prestige Consumer (PBH) Experiences Significant Decline - GuruFocus
How Prestige Consumer Healthcare Inc. (PBH) Affects Rotational Strategy Timing - Stock Traders Daily
Prestige Consumer Healthcare Inc (PBH) Shares Fall 11.3% -- What GF Score of 67 Tells Investors - GuruFocus
Prestige Consumer Healthcare forecasts $1.1B-$1.12B fiscal 2027 revenue with Clear Eyes growth weighted to the back half - MSN
Prestige Consumer (PBH) Downgraded by Oppenheimer Following Disa - GuruFocus
Prestige Consumer Hlthcr 4Q EPS $1.13 >PBH - Moomoo
Prestige Consumer Healthcare Inc. FY 2026: Revenue $1.09B, EPS $3.91— 10-K Summary - TradingView
OTC brand leader Prestige Consumer (PBH) outlines growth strategy and risks - Stock Titan
Prestige Consumer Healthcare Inc (PBH) 財務データ
収益
当期純利益
現金流量
EPS
5.02%
5.78%
大文字化:
|
ボリューム (24 時間):